Unlike other types of resistance that alter the effects of only one drug, ABC transporter expression confers cellular resistance to a wide variety of chemically and structurally unrelated anti-cancer agents, a phenomenon known as MDR[3,6,10-13]. The gene discussed is ABCG2; the disease is cancer.